My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 424

    1.

    Ceftazidime compared with piperacillin and tobramycin for the empiric treatment of fever in neutropenic patients with cancer. A multicenter randomized trial. The Intercontinental Antimicrobial Study Group.

    De Pauw BE, Deresinski SC, Feld R, Lane-Allman EF, Donnelly JP.

    Ann Intern Med. 1994 May 15;120(10):834-44.PMID: 8154643 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Ciprofloxacin plus piperacillin compared with tobramycin plus piperacillin as empirical therapy in febrile neutropenic patients. A randomized, double-blind trial.

    Peacock JE, Herrington DA, Wade JC, Lazarus HM, Reed MD, Sinclair JW, Haverstock DC, Kowalsky SF, Hurd DD, Cushing DA, Harman CP, Donowitz GR.

    Ann Intern Med. 2002 Jul 16;137(2):77-87.PMID: 12118962 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin as empiric therapy for fever in severely neutropenic patients.

    Marie JP, Marjanovic Z, Vekhoff A, Bouvet A, Chast F, Levy V, Baudard M, Legrand O, Rio B, Delmer A, Zittoun R.

    Support Care Cancer. 1999 Mar;7(2):89-94.PMID: 10089089 [PubMed - indexed for MEDLINE]Related articles

    4.

    Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer.

    Cometta A, Zinner S, de Bock R, Calandra T, Gaya H, Klastersky J, Langenaeken J, Paesmans M, Viscoli C, Glauser MP.

    Antimicrob Agents Chemother. 1995 Feb;39(2):445-52.PMID: 7726513 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Beta-lactam antibiotic therapy in febrile granulocytopenic patients. A randomized trial comparing cefoperazone plus piperacillin, ceftazidime plus piperacillin, and imipenem alone.

    Winston DJ, Ho WG, Bruckner DA, Champlin RE.

    Ann Intern Med. 1991 Dec 1;115(11):849-59.PMID: 1952471 [PubMed - indexed for MEDLINE]Related articles

    6.

    Clinical experience with single agent and combination regimens in the management of infection in the febrile neutropenic patient.

    Ramphal R, Gucalp R, Rotstein C, Cimino M, Oblon D.

    Am J Med. 1996 Jun 24;100(6A):83S-89S.PMID: 8678102 [PubMed - indexed for MEDLINE]Related articles

    7.

    Monotherapy with piperacillin/tazobactam versus combination therapy with ceftazidime plus amikacin as an empiric therapy for fever in neutropenic cancer patients.

    Hess U, Böhme C, Rey K, Senn HJ.

    Support Care Cancer. 1998 Jul;6(4):402-9.PMID: 9695210 [PubMed - indexed for MEDLINE]Related articles

    8.

    [Piperacilline/tazobactam combination+amikacin versus ceftazidime+amikacin in patients with neutropenia and fever. An open multicenter study. Groupe d'étude des Aplasies Fébriles]

    Marie JP, Vekhoff A, Cony-Makhoul P, Fière D, Guy H, Herbrecht R, Milpied N, Pico JL, Plantier I.

    Presse Med. 1995 Feb 25;24(8):397-401. French. PMID: 7899419 [PubMed - indexed for MEDLINE]Related articles

    9.

    Comparison of two antibiotic regimens (piperacillin plus amikacin versus ceftazidime plus amikacin) as empiric therapy for febrile neutropenic patients with cancer.

    Feliu J, Artal A, González Barón M, Berrocal A, Chacón I, García de Paredes ML, Espinosa E, Ordóñez A, Zamora P, Montero JM.

    Antimicrob Agents Chemother. 1992 Dec;36(12):2816-20.PMID: 1482151 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin for the treatment of patients with nosocomial lower respiratory tract infection. Piperacillin/tazobactam Nosocomial Pneumonia Study Group.

    Joshi M, Bernstein J, Solomkin J, Wester BA, Kuye O.

    J Antimicrob Chemother. 1999 Mar;43(3):389-97.PMID: 10223595 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Cefoperazone plus piperacillin versus mezlocillin plus tobramycin as empiric therapy for febrile episodes in neutropenic patients.

    Rotstein C, Cimino M, Winkey K, Cesari C, Fenner J.

    Am J Med. 1988 Jul 25;85(1A):36-43.PMID: 3041817 [PubMed - indexed for MEDLINE]Related articles

    12.

    A comparison of imipenem to ceftazidime with or without amikacin as empiric therapy in febrile neutropenic patients.

    Rolston KV, Berkey P, Bodey GP, Anaissie EJ, Khardori NM, Joshi JH, Keating MJ, Holmes FA, Cabanillas FF, Elting L.

    Arch Intern Med. 1992 Feb;152(2):283-91.PMID: 1739355 [PubMed - indexed for MEDLINE]Related articles

    13.

    Double beta-lactam regimen compared to an aminoglycoside/beta-lactam regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients.

    Joshi JH, Newman KA, Brown BW, Finley RS, Ruxer RL, Moody MA, Schimpff SC.

    Support Care Cancer. 1993 Jul;1(4):186-94.PMID: 8193880 [PubMed - indexed for MEDLINE]Related articles

    14.

    Treatment of febrile episodes in neutropenic leukemic patients with the antibiotic combinations piperacillin or ceftazidime plus amikacin: results of a randomized study.

    Fenu S, Raccah R, Santilli S, Micozzi A, Girmena C, Martino P, Avvisati G.

    Chemioterapia. 1988 Oct;7(5):323-6.PMID: 3066517 [PubMed - indexed for MEDLINE]Related articles

    15.

    Multicenter, randomized trial of ciprofloxacin plus azlocillin versus ceftazidime plus amikacin for empiric treatment of febrile neutropenic patients.

    Flaherty JP, Waitley D, Edlin B, George D, Arnow P, O'Keefe P, Weinstein RA.

    Am J Med. 1989 Nov 30;87(5A):278S-282S.PMID: 2686429 [PubMed - indexed for MEDLINE]Related articles

    16.

    Empiric treatment of hospital-acquired lower respiratory tract infections with meropenem or ceftazidime with tobramycin: a randomized study. Meropenem Lower Respiratory Infection Group.

    Sieger B, Berman SJ, Geckler RW, Farkas SA.

    Crit Care Med. 1997 Oct;25(10):1663-70. Erratum in: Crit Care Med 1997 Dec;25(12):2067. PMID: 9377880 [PubMed - indexed for MEDLINE]Related articles

    17.

    Comparative study of cefepime versus ceftazidime in the empiric treatment of pediatric cancer patients with fever and neutropenia.

    Mustafa MM, Carlson L, Tkaczewski I, McCracken GH Jr, Buchanan GR.

    Pediatr Infect Dis J. 2001 Mar;20(3):362-9. Review.PMID: 11303851 [PubMed - indexed for MEDLINE]Related articles

    18.

    A randomized study of ceftazidime compared to ceftazidime and tobramycin for the treatment of infections in cancer patients.

    Fainstein V, Bodey GP, Elting L, Bolivar R, Keating MJ, McCredie KB, Valdivieso M.

    J Antimicrob Chemother. 1983 Jul;12 Suppl A:101-10.PMID: 6352612 [PubMed - indexed for MEDLINE]Related articles

    19.

    Clinafloxacin monotherapy (CI-960) versus ceftazidime plus amikacin for empirical treatment of febrile neutropenic cancer patients.

    Glauser MP, Brennscheidt U, Cornely O, Grigg A, Figuera A, Keyserling C, Trostmann U, Welling L, Tack K.

    Clin Microbiol Infect. 2002 Jan;8(1):14-25.PMID: 11906496 [PubMed - indexed for MEDLINE]Related articles

    20.

    Meropenem versus ceftazidime in the treatment of cancer patients with febrile neutropenia: a randomized, double-blind trial.

    Feld R, DePauw B, Berman S, Keating A, Ho W.

    J Clin Oncol. 2000 Nov 1;18(21):3690-8.PMID: 11054442 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity